Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Network Type I Analysis

Type 1 network in which we propagated the absolute log regulation ratio abs(log(r/g)). We used the filtered lowest boundary of the confidence interval for the microarray measurement based and used the high confidence interaction map. Because type-I networks tend to favour highly connected proteins we tested a normalisation scheme in which we would run the network once with real values (the measured column) and once with simulated values where each measured point is set to 1 instead of the actual signal (the expected column). Afterwards we divided the measured value by the expected value. This normalisation scheme works to a certain extend but will lead to a variance that is directly related to the connectivity of each protein. In the end we dropped the use of Type-I networks due to the many technical problems they pose.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description measured expected final Hugo
Results: HTML CSV LaTeX
Showing element 1051 to 1100 of 3206 in total

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
measured\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
expected\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
final\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
Hugo\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1051\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RNA (GUANINE-7-) METHYLTRANSFERASE. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0429379\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.169867\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.252773641\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
RNMT\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1052\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ANNEXIN A7 (ANNEXIN VII) (SYNEXIN). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.149169\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.590289\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.252705031\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ANXA7\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1053\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CLATHRIN HEAVY CHAIN 1 (CLH-17). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.264806\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.04802\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.252672659\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
CLTC\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1054\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PHOSDUCIN-LIKE PROTEIN (PHLP). \vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.0344183\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.136218\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.252670719\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
PDCL\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
1055\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DNA REPAIR PROTEIN RAD52 HOMOLOG. \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
RAD52\vspace{3pt}}\\\cline{1-4}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
1056\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
REPLICATION PROTEIN A 70 KDA DNA-BINDING SUBUNIT (RP-A) (RF-A) (REPLICATION FACTOR-A PROTEIN 1) (SINGLE-STRANDED DNA-BINDING PROTEIN). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0688366\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.272436\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
RPA1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1057\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
REPLICATION PROTEIN A 32 KDA SUBUNIT (RP-A) (RF-A) (REPLICATION FACTOR-A PROTEIN 2). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.160828\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.636513\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.252670409\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
RPA2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1058\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PHOSDUCIN (PHD) (33 KDA PHOTOTRANSDUCING PROTEIN) (MEKA PROTEIN). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0280767\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.11112\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.252670086\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PDC\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1059\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CLATHRIN HEAVY CHAIN 2 (CLH-22). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.225517\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.892542\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.252668222\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
CLTCL1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1060\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GERM CELL-LESS. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.398407\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.57699\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.25263762\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1061\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PRE-B-CELL LEUKEMIA TRANSCRIPTION FACTOR-2 (HOMEOBOX PROTEIN PBX2) (G17 PROTEIN). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.294647\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.16629\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.252636137\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1062\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PRE-B-CELL LEUKEMIA TRANSCRIPTION FACTOR 4. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.122601\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.485287\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.252636069\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PBX4\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1063\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PRE-B-CELL LEUKEMIA TRANSCRIPTION FACTOR-3 (HOMEOBOX PROTEIN PBX3). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.283637\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.12271\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.252636032\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PBX3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1064\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
BAG-FAMILY MOLECULAR CHAPERONE REGULATOR-2. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.15369\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.608346\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.252635836\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
BAG2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1065\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HYPORTHETICAL PROTEIN MGC27169. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.118754\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.47006\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.252635834\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
C1orf179\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1066\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HOMEOBOX PROTEIN MEIS3 (MEIS1-RELATED PROTEIN 2) (FRAGMENT). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.285122\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.12859\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.25263559\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
MEIS3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1067\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HOMEOBOX PROTEIN MEIS1. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.352414\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.39495\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.252635578\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
MEIS1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1068\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HOMEOBOX PROTEIN MEIS2 (MEIS1-RELATED PROTEIN 1). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.322799\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.27773\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.252634751\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
MEIS2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1069\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PRE-B-CELL LEUKEMIA TRANSCRIPTION FACTOR-1 (HOMEOBOX PROTEIN PBX1) (HOMEOBOX PROTEIN PRL). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.301322\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.19272\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.252634315\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PBX1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1070\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.412942\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.63455\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.252633447\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
GMCL1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1071\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PROTEASOME SUBUNIT BETA TYPE 10 PRECURSOR (EC 3.4.25.1) (PROTEASOME MECL-1) (MACROPAIN SUBUNIT MECL-1) (MULTICATALYTIC ENDOPEPTIDASE COMPLEX SUBUNIT MECL-1). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0742909\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.294313\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.252421402\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
CTRL\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1072\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
IMPORTIN-ALPHA RE-EXPORTER (CHROMOSOME SEGREGATION 1-LIKE PROTEIN) (CELLULAR APOPTOSIS SUSCEPTIBILITY PROTEIN). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0342868\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.135906\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.252283196\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
CSE1L\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1073\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.832577\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3.30018\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.2522823\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
EIF2AK4\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1074\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
JUNCTION PLAKOGLOBIN (DESMOPLAKIN III). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0373336\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.147992\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.25226769\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
JUP\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1075\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TAX INTERACTION PROTEIN 1. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.281064\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.11415\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.252267648\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1076\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"EXONUCLEASE 1 ISOFORM B; RAD2 NUCLEASE FAMILY MEMBER, HOMOLOG OF S. CEREVISIAE EXONUCLEASE 1. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.03829\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.151786\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.252263055\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
EXO1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1077\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PHD FINGER PROTEIN 9. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0732296\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.290291\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.252262729\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
FANCL\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1078\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0349396\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.138505\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.252262373\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
UBE2W\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1079\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"SMALL OPTIC LOBES HOMOLOG; SMALL OPTIC LOBES, DROSOPHILA, HOMOLOG OF. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.177598\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.704023\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.252261645\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SOLH\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1080\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PRESENILINS ASSOCIATED RHOMBOID-LIKE PROTEIN. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.177185\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.702909\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.252073882\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PARL\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1081\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0370737\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.147075\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.252073432\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ZFAND1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1082\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"GAMMA-BUTYROBETAINE,2-OXOGLUTARATE DIOXYGENASE (EC 1.14.11.1) (GAMMA-BUTYROBETAINE HYDROXYLASE) (GAMMA-BBH). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0513934\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.203883\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.252073003\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
BBOX1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1083\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
POTENTIAL PHOSPHOLIPID-TRANSPORTING ATPASE IH (EC 3.6.3.1) (ATPASE CLASS I TYPE 11A) (ATPASE IS). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0225037\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.0892747\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.252072536\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ATP11A\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1084\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PROTEIN C20ORF4 (PROTEIN CGI-23) (PRO0225). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.145632\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.577812\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.252040456\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
C20orf4\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1085\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GDP-MANNOSE PYROPHOSPHORYLASE B ISOFORM 1; MANNOSE-1-PHOSPHATE GUANYLYLTRANSFERASE; AMPHOTERIN INDUCED GENE 3. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.223627\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.887589\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.251948819\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
GMPPB\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1086\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GDP-MANNOSE PYROPHOSPHORYLASE A; MANNOSE-1-PHOSPHATE GUANYLYLTRANSFERASE (GDP). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0389051\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.154417\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.251948296\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
GMPPA\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1087\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.189368\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.752124\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.251777632\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
RPAP3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1088\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"ADAPTOR-RELATED PROTEIN COMPLEX 1, MU 1 SUBUNIT (MU-ADAPTIN 1) (ADAPTOR PROTEIN COMPLEX AP-1 MU-1 SUBUNIT) (GOLGI ADAPTOR HA1/AP1 ADAPTIN MU-1 SUBUNIT) (CLATHRIN ASSEMBLY PROTEIN ASSEMBLY PROTEIN COMPLEX 1 MEDIUM CHAIN 1) (CLATHRIN COAT ASSEMBLY PROTEIN A"\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.168157\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.668251\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.251637484\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
AP1M1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1089\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.113583\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.451392\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.251628296\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
RSPH10B\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1090\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PHAFIN 2; PH AND FYVE DOMAIN-CONTAINING PROTEIN 2. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.2305\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.916205\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.251581251\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PLEKHF2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1091\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3-OXO-5-ALPHA-STEROID 4-DEHYDROGENASE 1 (EC 1.3.99.5) (STEROID 5-ALPHA-REDUCTASE 1) (SR TYPE 1) (S5AR). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0411277\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.163477\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.251580956\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SRD5A1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1092\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3-OXO-5-ALPHA-STEROID 4-DEHYDROGENASE 2 (EC 1.3.99.5) (STEROID 5-ALPHA-REDUCTASE 2) (SR TYPE 2) (5 ALPHA-SR2). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0324086\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.12882\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.2515805\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SRD5A2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1093\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"CASEIN KINASE II, ALPHA' CHAIN (CK II) (EC 2.7.1.37). \vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.23379\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.929536\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.251512583\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
CSNK2A2\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
1094\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"CASEIN KINASE II, ALPHA CHAIN (CK II) (EC 2.7.1.37). \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
CSNK2A1P\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1095\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"ADAPTOR-RELATED PROTEIN COMPLEX 1, MU 2 SUBUNIT (MU-ADAPTIN 2) (ADAPTOR PROTEIN COMPLEX AP-1 MU-2 SUBUNIT) (GOLGI ADAPTOR HA1/AP1 ADAPTIN MU-2 SUBUNIT) (CLATHRIN ASSEMBLY PROTEIN ASSEMBLY PROTEIN COMPLEX 1 MEDIUM CHAIN 2) (AP-MU CHAIN FAMILY MEMBER MU1B)."\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.138969\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.552694\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.251439314\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
AP1M2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1096\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PHOSPHOGLYCERATE MUTASE 2 (EC 5.4.2.1) (EC 5.4.2.4) (EC 3.1.3.13) (PHOSPHOGLYCERATE MUTASE ISOZYME M) (PGAM-M) (BPG-DEPENDENT PGAM 2) (MUSCLE-SPECIFIC PHOSPHOGLYCERATE MUTASE). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0270059\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.10746\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.251311186\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PGAM2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1097\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PUTATIVE PHOSPHOGLYCERATE MUTASE 3 (EC 5.4.2.1) (EC 5.4.2.4) (EC 3.1.3.13). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.030826\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.122661\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.251310522\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PGAM4\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1098\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.335885\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.33654\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.251309351\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
CCDC42\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1099\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PHOSPHOGLYCERATE MUTASE 1 (EC 5.4.2.1) (EC 5.4.2.4) (EC 3.1.3.13) (PHOSPHOGLYCERATE MUTASE ISOZYME B) (PGAM-B) (BPG-DEPENDENT PGAM 1). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0322794\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.128445\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.251309121\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1100\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ATP-CITRATE SYNTHASE (EC 2.3.3.8) (ATP-CITRATE (PRO-S-)-LYASE) (CITRATE CLEAVAGE ENZYME). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.157326\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.626348\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.251179855\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ACLY\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Hugo is the bloody hugo identifier as demanded by the BMC Bioinformatics idiots
- http://analysis.yellowcouch.org/